Superbugs & Superdrugs

16 - 17 March 2016

Conference

London, UK

The threat of antibiotic- resistant microbes poses one of the biggest economic and health threats in our time, as microbes are becoming more resistant and fewer drugs are passing clinical trials successfully.

Moreover, the increase in global migration accelerates the spread as we have seen from Mers and Ebola viruses, as well as over-consumption and hospital acquired infections.

This event will address the core challenges in the industry from: investment and R&D to hospital hygiene, and consumer engagement and review current strategies.

Organiser: SMi Group

www.superbugssuperdrugs.com/mchemist